ArticleAJOB empirical bioethics
Alzheimer's Disease Clinical Trial Decision-Making Among Patients with Mild Cognitive Impairment and Their Study Partners.
Chelsea G Cox, Adam I Birnbaum, Christian R Salazar, Megan Witbracht, Steven P Tam, Gaby T Thai, S Ahmad Sajjadi, Daniel L Gillen, Joshua D Grill
Abstract read
In one paragraphArticle in AJOB empirical bioethics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Chelsea G CoxDepartment of Health Behavior & Health Equity, University of Michigan School of Public Health, Ann Arbor, MI, USA.ORCID 0000-0002-5247-9119 Adam I BirnbaumDepartment of Statistics, University of California, Irvine, CA, USA.
Christian R SalazarInstitute for Memory Impairments & Neurological Disorders, University of California, Irvine, CA, USA.
Megan WitbrachtInstitute for Memory Impairments & Neurological Disorders, University of California, Irvine, CA, USA.
Steven P TamInstitute for Memory Impairments & Neurological Disorders, University of California, Irvine, CA, USA.
Gaby T ThaiInstitute for Memory Impairments & Neurological Disorders, University of California, Irvine, CA, USA.
S Ahmad SajjadiInstitute for Memory Impairments & Neurological Disorders, University of California, Irvine, CA, USA.
Daniel L GillenDepartment of Statistics, University of California, Irvine, CA, USA.
Joshua D GrillInstitute for Memory Impairments & Neurological Disorders, University of California, Irvine, CA, USA.
Funding
The Alzheimer's Disease Research Center at the University of California, IrvineP30AG066519 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Joshua Grill · 2020 to 2026
$27.9MInstitute for Clinical and Translational ScienceUM1TR004927 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI DAN M COOPER, Eric J. Vilain · 2024 to 2026
$12.2MInterdisciplinary Research Training on Health and AgingT32AG027708 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Lindsay C Kobayashi, Briana Mezuk · 2008 to 2026
$2.7MImproving Hispanic/Latino participation in preclinical Alzheimers disease TrialsK01AG076811 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christian R Salazar · 2022 to 2026
$681kNCATS NIH HHS UM1 TR004927NIA NIH HHS K01 AG076811NIA NIH HHS P30 AG066519NIA NIH HHS T32 AG027708
6 · The paper itselfAbstract
Indexed as
Alzheimer DiseaseClinical Trials as TopicCognitive DysfunctionDecision MakingInformed ConsentSpousesAgedAged, 80 and overComprehensionFemaleHumansMaleMental CompetencyMiddle AgedPatient ParticipationProdromal SymptomsAlzheimer’s diseaseclinical trialsdecision-makingmild cognitive impairment
Identifiers
PMID41147833
PMCPMC12593232
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390